SRAX Crescita futura

Future criteri di controllo 0/6

Al momento non disponiamo di una copertura analitica sufficiente per prevedere la crescita e il fatturato di SRAX.

Informazioni chiave

n/a

Tasso di crescita degli utili

n/a

Tasso di crescita dell'EPS

Software crescita degli utili	16.9%
Tasso di crescita dei ricavi	n/a
Rendimento futuro del capitale proprio	n/a
Copertura analitica	None
Ultimo aggiornamento	n/a

Aggiornamenti recenti sulla crescita futura

Recent updates

In questa sezione di solito presentiamo le proiezioni di crescita dei ricavi e degli utili basate sulle stime di consenso degli analisti professionisti per aiutare gli investitori a capire la capacità della società di generare profitti. Tuttavia, poiché SRAX non ha fornito dati sufficienti sul passato e non ha previsioni degli analisti, i suoi utili futuri non possono essere calcolati in modo affidabile estrapolando i dati passati o utilizzando le previsioni degli analisti.

Si tratta di una situazione piuttosto rara, dato che il 97% delle società coperte da SimplyWall St dispone di dati finanziari passati.

Previsioni di crescita degli utili e dei ricavi

OTCPK:SRAX - Stime future degli analisti e dati finanziari passati (USD Millions )
Data	Ricavi	Guadagni	Flusso di cassa libero	Liquidità dell'operazione	Avg. Numero di analisti
12/31/2022	28	-32	-13	-12	N/A
9/30/2022	28	-22	-14	-13	N/A
6/30/2022	30	-21	-19	-18	N/A
3/31/2022	29	-3	-24	-23	N/A
12/31/2021	27	-10	-24	-23	N/A
9/30/2021	21	-6	-23	-22	N/A
6/30/2021	17	-4	-22	-21	N/A
3/31/2021	11	-11	-17	-17	N/A
12/31/2020	6	-10	-14	-13	N/A
9/30/2020	5	-19	-14	-13	N/A
6/30/2020	4	-11	-13	-12	N/A
3/31/2020	3	-14	-16	-15	N/A
12/31/2019	4	-17	-17	-15	N/A
9/30/2019	4	-21	-19	-17	N/A
6/30/2019	5	-1	-23	-22	N/A
3/31/2019	8	3	-17	-16	N/A
12/31/2018	10	9	-15	-14	N/A
9/30/2018	15	10	-12	-11	N/A
6/30/2018	19	-14	-4	-3	N/A
3/31/2018	20	-11	-5	-4	N/A
12/31/2017	23	-13	-5	-4	N/A
9/30/2017	28	-8	-5	-4	N/A
6/30/2017	32	-7	-4	-4	N/A
3/31/2017	36	-4	-2	-2	N/A
12/31/2016	36	-4	-1	-1	N/A
9/30/2016	32	-3	N/A	3	N/A
6/30/2016	30	-2	N/A	0	N/A
3/31/2016	32	-3	N/A	1	N/A
12/31/2015	30	-3	N/A	1	N/A
9/30/2015	26	-4	N/A	-1	N/A
6/30/2015	19	-4	N/A	-1	N/A
3/31/2015	9	-6	N/A	-3	N/A
12/31/2014	5	-4	N/A	-2	N/A
9/30/2014	3	-3	N/A	-2	N/A
6/30/2014	4	-3	N/A	-2	N/A
3/31/2014	4	-2	N/A	-1	N/A
12/31/2013	3	-2	N/A	0	N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: Dati insufficienti per determinare se la crescita degli utili prevista SRAX è superiore al tasso di risparmio ( 2.6% ).

Guadagni vs Mercato: Dati insufficienti per determinare se si prevede che gli utili di SRAX cresceranno più velocemente del mercato US

Guadagni ad alta crescita: Dati insufficienti per determinare se si prevede che gli utili di SRAX cresceranno in modo significativo nei prossimi 3 anni.

Ricavi vs Mercato: Dati insufficienti per determinare se si prevede che i ricavi di SRAX cresceranno più rapidamente del mercato US.

Ricavi ad alta crescita: Dati insufficienti per determinare se si prevede che i ricavi di SRAX cresceranno più rapidamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Dati insufficienti per determinare se il Return on Equity di SRAX è previsto essere elevato tra 3 anni

SRAX Crescita futura

Future criteri di controllo 0/6

Informazioni chiave

Aggiornamenti recenti sulla crescita futura

Forecast breakeven date pushed back to 2023

Price target increased to US$10.50

Price target increased to US$10.50

SRAX, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2022

SRAX, Inc. Provides Revenue Guidance for the First Quarter and Full Year of 2022

Consensus forecasts updated

Recent updates

DNA Holdings LLC entered into a definitive merger agreement to acquire remaining 65% stake in SRAX, Inc. (OTCPK:SRAX).

SRAX, Inc. announced that it has received $0.075 million in funding

SRAX, Inc. announced that it has received $0.075 million in funding

SRAX, Inc. Announces Resignation of Board Members

Alan Urban Resigns as the Chief Financial Officer of SRAX, Inc

New major risk - Market cap size

First quarter 2022 earnings released: EPS: US$0.14 (vs US$0.57 loss in 1Q 2021)

Forecast breakeven date pushed back to 2023

SRAX, Inc., Annual General Meeting, Dec 31, 2022

Price target increased to US$10.50

SRAX, Inc. Launches the Sequire Investor Community Platform

SRAX Announces Receipt of Nasdaq Listing Determination

SRAX gets Nasdaq delisting notice, plans to appeal decision

Full year 2021 earnings released: US$0.41 loss per share (vs US$0.69 loss in FY 2020)

SRAX, Inc. Announces the Arcimoto Sweepstakes

SRAX Announces Receipt of Anticipated Nasdaq Notice of Additional Delinquency

Srax receives Nasdaq notice of additional delinquency

Is There An Opportunity With SRAX, Inc.'s (NASDAQ:SRAX) 50% Undervaluation?

Price target increased to US$10.50

SRAX announces $9.5M revolving credit facility

SRAX, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2022

SRAX, Inc. announced delayed 10-Q filing

SRAX, Inc. Receives Non-Compliance Notice from Nasdaq

SRAX, Inc. announced delayed annual 10-K filing

SRAX, Inc. Provides Revenue Guidance for the First Quarter and Full Year of 2022

Is SRAX (NASDAQ:SRAX) A Risky Investment?

SRAX Offers Value Here

Third quarter 2021 earnings released: US$0.15 loss per share (vs US$0.45 loss in 3Q 2020)

Second quarter 2021 earnings released: US$0.24 loss per share (vs US$0.38 loss in 2Q 2020)

Does SRAX (NASDAQ:SRAX) Have A Healthy Balance Sheet?

SRAX Is Booming, Except The Share Price

Consensus forecasts updated

SRAX, Inc. (NasdaqCM:SRAX) announces an Equity Buyback for $10 million worth of its shares.

Price target increased to US$9.75

SRAX Releases the 1x1 Meeting Feature on the Sequire Virtual Events Platform

SRAX Has Plenty Of Room To Run

SRAX, Inc. announced delayed 10-Q filing

SRAX, Inc. Provides Revenue Guidance for the Second Quarter of Fiscal 2021

Full year 2020 earnings released: US$0.92 loss per share (vs US$1.36 loss in FY 2019)

SRAX, Inc. Provides Revenue Guidance for the Second Quarter Of Fiscal Year 2021

SRAX, Inc. Releases the Shelf Registration Feature on the Sequire Platform

Brock Pierce Joins SRAX Board of Directors

SRAX trades high on Sequire platform reporting 3M retail investors

New 90-day high: US$3.95

Does SRAX (NASDAQ:SRAX) Have A Healthy Balance Sheet?

New 90-day high: US$3.12

Analysts update estimates

SRAX, Inc., Annual General Meeting, Dec 31, 2020

Third quarter 2020 earnings released: US$0.45 loss per share

SRAX EPS misses by $0.14, beats on revenue

An undisclosed buyer acquired the remaining stake in the MD Asset of SRAX, Inc. (NasdaqCM:SRAX) for $8 million.

New 90-day low: US$2.34

SRAX, Inc. Announces Resignation of Kristoffer Nelson as Chief Operating Officer and as a Member of the Board, Effective October 16, 2020

SRAX, Inc. announced that it has received $14 million in funding from Serra Ventures, LLC

SRAX, Inc. (NasdaqCM:SRAX) completed the acquisition of LD Micro, Inc.

Analysts increase revenue estimates to US$5.72m

Analysts update estimates

New 90-day high - US$2.80

SRAX, Inc. announced that it has received $13 million in funding

SRAX, Inc.(NasdaqCM:SRAX) dropped from Russell Microcap Growth Index

SRAX, Inc. announced that it has received $11.8 million in funding

Previsioni di crescita degli utili e dei ricavi

Previsioni di crescita futura degli analisti

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

Scoprire le aziende in crescita